CGI and Hexoskin to Work Together on Connected Medical Clinic Project

The Canadian Space Agency (CSA) has awarded contracts to five teams to build prototypes of the Connected Care Medical Module (C²M²), a container-based concept for mobile medical clinics that can be rapidly deployed in remote, northern, or indigenous communities across Canada, in regions affected by natural disasters, and in future lunar and deep space missions.

Hexoskin (Carré Technologies Inc.) is proud to be part of the HARMONY team, led by CGI, one of the largest IT firms in the world, along with OKAKI Health Intelligence, PrecisionOS Technology, 12Volt: Games Studio, and Dr. Carolyn McGregor of the University of Ontario Institute of Technology.

Hexoskin will contribute Astroskin devices and AI-based medical software to the project. A first demonstration is planned for June 2023.


About the Connected Care Medical Modules

Health Beyond's vision is to enable agile, rapid prototyping and iterative operation of C²M²s on Earth, with the ultimate objective of operation in space. A C²M² is a scalable integrated system of state-of-the-art medical technologies and methodologies contained in a deployable unit. A shipping container will first be used for research and development purposes and for easy deployment across Canada via the existing intermodal freight transportation network. When preparing for space application and deployment in remote communities with collaborators, the medical module can be scaled down and adapted as needed.

One of the novel features of the C²M² is its core computer-based system that facilitates the incorporation, interconnection (i.e., flow of information), and usage of the latest medical technologies. This plug and play architecture will enable multiple configurations based on the end users' needs. These technologies increase the user's capacity to independently detect, diagnose, treat, and/or monitor health conditions on site. This improves the timeliness, quality, and continuity of care; refines clinical decision-making; and reduces the occurrence of risky and expensive medical transportation of patients from remote regions to urban hospital facilities.

(photo: Canadian Space Agency)

Hexoskin Talks Space Medicine at the Healthcare without Boundaries Colloquium

Biomedical researcher Héloïse Auger will talk about Hexoskin's work in space medicine, Astroskin wearable sensors, and artificial intelligence for automated diagnostics at the Healthcare without Boundaries Colloquium this week on June 1-2. Registration is available on Eventbrite: Healthcare without Boundaries Colloquium

Hexoskin has been collaborating with the Canadian Space Agency since 2011 on the development of medical technologies that can be used for human spaceflight. Devices that can record health data passively, like the Astroskin, create an opportunity to develop autonomous medical systems using clinical rules and artificial intelligence to support long-term space missions beyond low Earth orbit.

Astrokin wearable sensors worn by Canadian astronaut David Saint-Jacques in the International Space Station, January 2019
Are you working on a research project that requires monitoring cardiorespiratory activity in real-life settings? Contact us to discuss your objectives and see how Astroskin or Hexoskin could be useful! 
October 21, 2019

Artificial Intelligence › publications ›

Hexoskin takes part in the AAIH reflection about Artificial Intelligence in Healthcare

The Alliance for Artificial Intelligence in Healthcare (AAIH) just published a white paper titled "A Primer on AI in Healthcare".

The Primer on AI in Healthcare attempts to cover many uses for AI in healthcare in a way that is accessible, but also as precise and concrete as possible. We hope this document will serve as a reference for future discussions and publications for all stakeholders in healthcare and AI, including patients and providers.

A Primer on Artificial Intelligence in Healthcare - A technical introduction
The 45-page document describes AI approaches and applications in healthcare and biopharma research, and helps introduce standard definitions for the industry.

The Hexoskin Team is proud to have taken part in this reflection that will drive the future of AI development for Connected Health in healthcare.

"It was important for me to contribute to this essential white paper. There was a need to clarify terms and concepts in AI with an emphasis on applications in healthcare, biomedical discovery, clinical development, and home care". Pierre-Alexandre-Fournier - CEO at Hexoskin.


About Hexoskin
Founded in 2006 in Montreal, Hexoskin (Carré Technologies Inc.) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

September 09, 2019

Artificial Intelligence › Conventions & Events ›

Hexoskin presents its data-driven model for algorithms development and AI services at Intelligent Health 2019, in Basel

On September 12th this week, Hexoskin's Co-founder & CTO Jean-François Roy will discuss sensors, data, and AI in medicine at the Intelligent Health AI conference in Basel, Switzerland.

Hexoskin has been chosen among only 5 companies in the world to present at the Showcase event at the conference sponsored by Novartis. Hexoskin's Chief Technology Officer Jean-François Roy will present new opportunities for healthcare and pharmaceutical organizations to uncover new insights from the data they have collected from clinical trials.

Artificial Intelligence and Machine Learning have the potential to transform drug development and reduce the time to market of much-needed therapies in various therapeutic areas, including rare diseases, and find new cures for millions of patients.

The Hexoskin end-to-end data platform is secure and platform agnostic. Hexoskin's clients have access to cost-effective tools to manage clinical studies, collect rich health data, and build unique databases and datasets for machine learning & AI projects.

Hexoskin has a dedicated group of AI & biomedical researchers with years of experience in preparing and analyzing health data, and in the development of machine learning algorithms with health data. Its research team collects new vital signs data and use external datasets to answer novel research questions.



“Hexoskin was founded in 2006 to develop sensors and information systems to support Artificial Intelligence applications for clinical research and healthcare”.

  • Jean-François Roy is CTO and co-founder of Hexoskin (Carré Technologies Inc.). Since 2006 he leads the R&D company development to develop wearable biosensors and mobile applications.  He is a specialist in embedded systems, an experienced ASIC, FPGA and board designer. He also developed signal processing algorithms in many programming languages. He’s been involved with the design, development, integration, and testing of the Hexoskin/Astroskin system and related biomedical technologies since 2006.

 About Hexoskin:

Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.

The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 70 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients including pharmaceuticals, research centers, government agencies, and healthcare providers.

Live Webinar - Join Us for the upcoming Hexoskin Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin

Join Us for our Hexoskin Live Webinar on February 27th! 

We invite you to attend our Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin, that will cover the latest fields of applications & research studies. Our guest speaker, Thomas Beltrame, PhD, will discuss his work with his fellow research team at University of Waterloo to evaluate cardiovascular & respiratory health with Hexoskin and machine learning.

We will also present how the Hexoskin and Astroskin end-to-end platforms can support research and professional organizations for their Machine Learning & Artificial Intelligence projects.

Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin
Wednesday, February 27, 2019, at 12:00 PM (EST) - via the Zoom Video Conferencing software

Pierre-Alexandre Fournier
CEO & Co-Founder, Hexoskin

Thu Ngan Trinh PhD
Clinical Applications Specialist, Hexoskin

Guest Speaker: 
Thomas Beltrame PhD
Department of Physiotherapy - Federal University of São Carlos
Institute of Computing - University of Campinas

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward. 

We look forward to your presence for this special event!

Hexoskin - AI Applications Summit Biopharma Boston

Our team will attend the AI Applications Summit Biopharma in Boston this week (October 25-26).

Hexoskin was founded in 2006 to develop sensors and information systems to support Artificial Intelligence applications for clinical research and healthcare. Over the years, we've worked with many organisations to develop systems to make a better use of clinical data, and we've learned a few things from it:

  • Great AI needs great data: data collection is the foundation of all AI work.
  • 90% of AI work is in processing and annotating data. AI modeling is the "easy" part.
  • Define valuable endpoints first, then define how to collect the relevant data to build your models.
  • When using connected devices and mobile devices for data collection, design a patient-centric pilot trial first to validate human factor assumptions.

There's a lot more to know to operationalize AI projects in clinical trials of course. Even when working with a technological partner, you'll need to have people in your team with the skills to manage the digital component of the project. Please reach out to us if you need advice on best practices and operations.

In short, there's a lot of opportunity for AI in clinical trials, from patient recrutement to data modeling, including virtual trials and phase IV trials. We're looking forward to share insights with you in Boston this week!


Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. For more information, write us at, and visit and @Hexoskin on Twitter.

Using Wearables, Data, and AI in Clinical Trials

Montréal InVivo hosted an event today in Laval, Québec, to discuss the use of data and AI in clinical trials. Representatives from Alta Sciences, a CRO focused on phase I/II trials in Canada and the US, and Accreon (Health IT), joined Hexoskin to discuss strategies and best practices.

On the picture below you can see Marc Paquin, Director of Partnerships and Business Development, sharing Hexoskin's experience with wearable sensors & AI software development for clinical trials.

Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. For more information, write us at, and visit and @Hexoskin on Twitter.

February 13, 2018

Artificial Intelligence ›

AI and the Future of Health

Hexoskin was founded in 2006 to solve healthcare challenges related to population aging. Since then, our team has contributed to science & society by creating analysis and prediction algorithms, and our platform has been used to generate high-resolution data for clinical research, space medicine, and elite athletes.

Hexoskin's vision, from its inception, was to create Artificial Intelligence models (AI) and make health data more accessible and useful. Better data and intelligence facilitate prevention, prediction, and management of chronic conditions to reduce hospitalization rates and provide better patient outcomes for a given budget. It helps patients and providers better communicate.

However, healthcare AI needs relevant and accurate data to learn from. This means you need a digital infrastructure that measures health where and when it matters, and makes data accessible for analysis. This is why we've designed the Hexoskin Smart Garment platform: to collect user's cardiac, respiratory, and physical activity information. We've built convenient tools to get good data from active and chronic patients. We believe good design makes it easier for users to provide the data AI needs to be effective.

Artificial intelligence combined with the data collected by Hexoskin Smart Garments make it possible to predict a variety of conditions and anticipate them with more efficiency. We'll be presenting some of our work in Houston next week, you can register for the event here.


Speakers from Hexoskin, Rice University and Texas Children's Hospital will be in Houston February 21st, 2018 to talk about AI, Machine Learning and Healthcare. Register today here


Some Artificial Intelligence papers published with Hexoskin data:

Evaluating a Potential Commercial Tool for Healthcare Application for People with Dementia
Banerjee, T. et al. Kno.e.sis Publications, #1063, 2015.

Aerobic System Analysis Based on Oxygen Uptake and Hip Acceleration During Random Over-Ground Walking Activities
Beltrame, T. et al. Am J Physiol Regul Integr Comp Physiol, 312: R93-R100, 2017.

ADA - Automatic Detection of Alcohol Usage for Mobile Ambulatory Assessment
Sun, P. et al. IEEE International Conference on Smart Computing (SMARTCOMP), 2016.

Predicting Cognitive States from Wearable Recordings of Autonomic Function
Webster, E. et al. IBM J. Res. Dev. Vol. 6, No. 2/3, pp 2:1-2:11, 2017.

About Hexoskin
Hexoskin is a biometric smart garment, designed and made in Canada, that allows precise long-term monitoring of activity, cardiac and respiratory function as well as sleep quality. Hexoskin’s non-invasive solution is made of high-performance Italian fabric that is lightweight, quick dry, breathable and antibacterial. Hexoskin garment is made for real-life daily activities and is comfortable under regular clothes. The Hexoskin biometric garments are the only clinically validated solution for long-term remote monitoring of cardiorespiratory functions and activity.

Presenting An AI Approach to Maximize Pipeline Value at DPharm

This year again, Hexoskin is attending the DPharm Conference, taking place in Boston September 6-8.

On September 7th, Hexoskin's CEO Pierre-Alexandre Fournier, will talk about opportunities for Pharma companies to uncover new insights from the data they have collected from trials, and how to take advantage of AI/machine learning advances to maximize pipeline value.

Hexoskin has been developing machine learning and data mining algorithms since 2006. With its wearable health sensors, it has accumulated terabytes of health data from thousands of users. The company has a long experience in dealing with large datasets, and is working with healthcare and pharmaceutical organizations to unlock value from clinical trials data, health research, and more.


View full article →

Hexoskin Presents Tools for Chronic Care at the AI in Healthcare Summit in San Francisco

Hexoskin is attending the AI in Healthcare Summit in San Francisco this week to present its connected health platform and healthcare AI architecture on Monday, June 26th.

The current hospital system has been built around the treatment of acute illness: emergencies, injuries, infections, etc. Chronic diseases are changing healthcare, and we are now entering a future in which care delivery is becoming decentralized, where communication between health professionals and patients is being facilitated by technology, leading to many potential advancements in prevention, treatment of chronic illness, and much more.

In his talk, Hexoskin's CEO Pierre-Alexandre Fournier discusses the specific tools enabling these advancements, what challenges exist in using health data for AI, and how healthcare professionals can leverage these new technologies to improve the quality of life for chronically ill patients.

Hexoskin at the AI in Healthcare Summit - San Francisco June 26-27, 2017

The Hexoskin software research platform is designed to generate continuous health data for the development of Artificial Intelligence (machine learning) algorithms for chronic diseases management. Hexoskin also offers AI and data science services to healthcare and pharma companies.

Hexoskin is the world leader in smart clothing and body sensing technologies. The company has announced last year it will equip the International Space Station (ISS) with a bio-monitoring system for astronauts in collaboration with NASA and the Canadian Space Agency.

The Montreal Heart Institute is currently completing a clinical trial with Hexoskin biometric shirts with angina patients undergoing therapy. One of the goals of the study is to develop a new vitality index using Hexoskin biometric shirts to assess angina and to monitor the rehabilitation of cardiac patients.

About Hexoskin

Hexoskin is the world leader in smart clothing for health monitoring. Hexoskin smart shirts are used by space and defense agencies, sports scientists, and thousands of health professionals and health researchers all over the world. The Hexoskin connected platform provides a new, convenient way to understand human health in real-life environments. For more information, write us at, and visit and @Hexoskin on Twitter.


CAUTION - Hexoskin products and services are not intended, and should not be used to investigate, diagnose, monitor, treat or prevent disease or other medical conditions nor to provide information for medical or diagnostic purposes.